Literature DB >> 2918672

HIV seroprevalence in newborns in New York State.

L F Novick1, D Berns, R Stricof, R Stevens, K Pass, J Wethers.   

Abstract

The prevalence of human immunodeficiency virus (HIV) infection was determined in women at the time of childbirth throughout New York State between November 30, 1987, and November 30, 1988. Mandatory blood specimens (276,609) obtained from all newborns were examined for HIV. The overall HIV seroprevalence rate was 0.66% (1816 newborns), with 0.16% in Upstate New York and 1.25% in New York City. Rates for newborns whose mothers were aged 20 to 29 years (1.30%) and 30 to 39 years (1.35%) were significantly higher than rates for those with mothers younger than 20 years of age (0.72%). Rates of seropositivity were higher among blacks (1.8%) and Hispanics (1.3%) than among whites (0.13%). Seropositivity of HIV was higher in zip code areas with high rates of drug use (2.2%) than in the rest of New York City (0.8%). It is estimated that more than 726 HIV-infected children were born in New York State during the 1-year study period, using 40% as the probable proportion of seropositives that will become infected.

Entities:  

Mesh:

Year:  1989        PMID: 2918672

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  28 in total

Review 1.  Prevention of HIV among adolescents.

Authors:  M J Rotheram-Borus; Z O'Keefe; R Kracker; H H Foo
Journal:  Prev Sci       Date:  2000-03

2.  Improving estimates of HIV-1 seroprevalence among childbearing women: use of smaller blood spots.

Authors:  N J Hoxie; J M Vergeront; J R Pfister; G L Hoffman; P A Markwardt-Elmer; J P Davis
Journal:  Am J Public Health       Date:  1992-10       Impact factor: 9.308

3.  Geographic distribution of newborn HIV seroprevalence in relation to four sociodemographic variables.

Authors:  D L Morse; L Lessner; M G Medvesky; D M Glebatis; L F Novick
Journal:  Am J Public Health       Date:  1991-05       Impact factor: 9.308

4.  Newborn seroprevalence study: methods and results.

Authors:  L F Novick; D M Glebatis; R L Stricof; P A MacCubbin; L Lessner; D S Berns
Journal:  Am J Public Health       Date:  1991-05       Impact factor: 9.308

5.  To tell or not to tell: the ethical dilemmas of HIV test notification in epidemiologic research.

Authors:  A L Avins; B Lo
Journal:  Am J Public Health       Date:  1989-11       Impact factor: 9.308

Review 6.  Perinatal effects of cocaine and amphetamine use during pregnancy.

Authors:  S R Kandall
Journal:  Bull N Y Acad Med       Date:  1991 May-Jun

7.  Methods of surveillance for HIV infection at U.S. sentinel hospitals.

Authors:  M E St Louis; N Olivo; S Critchley; K J Rauch; C R White; V P Munn; T J Dondero
Journal:  Public Health Rep       Date:  1990 Mar-Apr       Impact factor: 2.792

8.  HIV seroprevalence surveys of childbearing women--objectives, methods, and uses of the data.

Authors:  M Pappaioanou; J R George; W H Hannon; M Gwinn; T J Dondero; G F Grady; R Hoff; A D Willoughby; A Wright; A C Novello
Journal:  Public Health Rep       Date:  1990 Mar-Apr       Impact factor: 2.792

9.  Using seroprevalence data in managing public health programs.

Authors:  I M Onorato; T S Jones; W R Forrester
Journal:  Public Health Rep       Date:  1990 Mar-Apr       Impact factor: 2.792

10.  What is the dentist's occupational risk of becoming infected with hepatitis B or the human immunodeficiency virus?

Authors:  E I Capilouto; M C Weinstein; D Hemenway; D Cotton
Journal:  Am J Public Health       Date:  1992-04       Impact factor: 9.308

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.